Notes to SEFA
Title: Note 1 - Basis of Presentation
Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting. Pass-throughentity identifying numbers are presented where available.
De Minimis Rate Used: N
Rate Explanation: The Institute has submitted an indirect rate proposal. An indirect rate has been applied to the grantsusing the rate of 79.74 percent.
The accompanying schedule of expenditures of federal awards (the "Schedule") includes the federal grant activity of the Institute under programs of the federal government for the year ended June 30, 2023. The information in this schedule is presented in accordance with the requirements of the Office of Management and Budget (Uniform Guidance), Audits of States, Local Government, and Non-Profit Organizations. Because the schedule presents only a selected portion of the operations of the Institute, it is not intended to and does not present the financial position, changes in net assets or cash flows of the Institute.
Title: Note 2 - Summary of Significant Accounting Policies
Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting. Pass-throughentity identifying numbers are presented where available.
De Minimis Rate Used: N
Rate Explanation: The Institute has submitted an indirect rate proposal. An indirect rate has been applied to the grantsusing the rate of 79.74 percent.
Expenditures reported on the schedule are reported on the accrual basis of accounting. Pass-through entity identifying numbers are presented where available.
Title: Note 3 - Subrecipients
Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting. Pass-throughentity identifying numbers are presented where available.
De Minimis Rate Used: N
Rate Explanation: The Institute has submitted an indirect rate proposal. An indirect rate has been applied to the grantsusing the rate of 79.74 percent.
Out of the federal expenditures presented in the Schedule, the Institute provided federal awards to subrecipients as follows: Federal
Assistance
Listing Number Programs Name
Amount
provided to
Subrecipients
93.866 Aging Research
Pre-Clinical Studies - U01AG060965
U01AG060965 Subaward #4008-UCI-DHC-2020 $ 21,916
R01 Clinical Studies Phase 1 Trials R01AG074983
Banner Clinical Trial Subaward 15,054
Sultzer Clinical Trial Subaward 50,919
Schneider Clinical Trial Subaward 143,408
Abeta - RF1AG020241
RF1AG020241 Subaward #4001-UCI-DHC-2018 126,283
RF1AG020241 Subaward #4001-UCI-MBJ-2018 127,961
Total Amount Passed Through for 93.866 485,541
Total Federal Award(s) Passed Through to Subrecipients $ 485,541
Title: Note 4 - Indirect Cost Rate
Accounting Policies: Expenditures reported on the schedule are reported on the accrual basis of accounting. Pass-throughentity identifying numbers are presented where available.
De Minimis Rate Used: N
Rate Explanation: The Institute has submitted an indirect rate proposal. An indirect rate has been applied to the grantsusing the rate of 79.74 percent.
he Institute has submitted an indirect rate proposal. An indirect rate has been applied to the grants using the rate of 79.74 percent.